Disease Markers / 2019 / Article / Tab 9

Research Article

Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals

Table 9

Association between the risk of NAFLD during the observation period (year) and the combination of weigh status at baseline and the ADRB3 rs4994 genotype in the Cox proportional hazard model.

Weight statusADRB3 genotypeHR [95% CI] value

Normal-weightT allele1
3.66 [0.45–30.15]

Overweight/obeseT allele3.53 [1.42–8.79]<0.01
C/C10.03 [2.04–49.37]<0.01

ADRB3: beta-3-adrenergic receptor; NAFLD: nonalcoholic fatty liver disease; HR: hazard ratio; CI confidence interval. Adjusted by age, HOMA-IR, and dyslipidemia. Analyzed using a Cox proportional hazard model.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.